Cargando…
DUX4 is a common driver of immune evasion and immunotherapy failure in metastatic cancers
Cancer immune evasion contributes to checkpoint immunotherapy failure in many patients with metastatic cancers. The embryonic transcription factor DUX4 was recently characterized as a suppressor of interferon-γ signaling and antigen presentation that is aberrantly expressed in a small subset of prim...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cold Spring Harbor Laboratory
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369889/ https://www.ncbi.nlm.nih.gov/pubmed/37502871 http://dx.doi.org/10.1101/2023.07.10.548412 |